Article | June 4, 2021

5 Key Takeaways: Drug And Device Development Secrets In The World Of Medical Aesthetics

By Jasmina Jankicevic, Nach Davé and Marlis Sarkany

plastic surgery iStock-1285284252

New treatment options for medical aesthetic indications are in record-high demand, fueled by growing awareness of the effects of physiological and environmental aging and the influence of lifestyle on skin health. By 2025, the global aesthetic medicine market is projected to be $22.8 billion, nearly one-third of which is expected to be dermal fillers.

Premier Research explored this evolving landscape in depth in our recent webinar Drug and Device Development Secrets in the World of Medical Aesthetics. Presenters Jasmina Jankicevic, Vice President, Medical Affairs, Dermatology & Medical Aesthetics; Nach Davé, Vice President, Development Strategy; and Marlis Sarkany, Senior Medical Director, discussed trends and opportunities, regulatory considerations, and protocol design and study implementation for medical aesthetics. In this blog, we discuss five of the most important takeaways for creating a competitive, differentiated aesthetic development program.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Cell & Gene? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: